These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 564164)

  • 1. The inhibition of activated bovine coagulation factors X and VII by antithrombin III.
    Jesty J
    Arch Biochem Biophys; 1978 Jan; 185(1):165-73. PubMed ID: 564164
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of antithrombin III on the activity of the coagulation factors VII, IX and X.
    Osterud B; Miller-Andersson M; Abildgaard U; Prydz H
    Thromb Haemost; 1976 Apr; 35(2):295-304. PubMed ID: 61631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of bovine factor IXa and factor Xabeta by antithrombin III.
    Kurachi K; Fujikawa K; Schmer G; Davie EW
    Biochemistry; 1976 Jan; 15(2):373-7. PubMed ID: 1247523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive inactivation of purified factor VII by heparin and antithrombin III.
    Godal HC; Rygh M; Laake K
    Thromb Res; 1974 Dec; 5(6):773-5. PubMed ID: 4445996
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of heparin in the inactivation of thrombin, factor Xa, and plasmin by antithrombin III.
    Stürzebecher J; Markwardt F
    Thromb Res; 1977 Dec; 11(6):835-46. PubMed ID: 146278
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of activated factor X in the control of bovine coagulation factor VII.
    Morrison-Silverberg SA; Jesty J
    J Biol Chem; 1981 Feb; 256(4):1625-30. PubMed ID: 7462215
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of activated coagulation factor VII by normal human plasma.
    Dahl PE; Abildgaard U; Larsen ML; Tjensvoll L
    Thromb Haemost; 1982 Dec; 48(3):253-6. PubMed ID: 7164015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of activated factors II, VII, IX, and X by synthetic organic compounds directed against the active-site seryl residue.
    Van der Woerd-de Lange JA; van Dam-Mieras MC; Hemker HC
    Haemostasis; 1981; 10(6):315-47. PubMed ID: 6976920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor-Xa inactivation by antithrombin. 3. Evidence for biological stabilization of factor Xa by factor V-phospholipid complex.
    Marciniak E
    Br J Haematol; 1973 Mar; 24(3):391-400. PubMed ID: 4713637
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of human, bovine, and horse antithrombin III.
    Kurachi K; Schmer G; Hermodson MA; Teller DC; Davie EW
    Biochemistry; 1976 Jan; 15(2):368-73. PubMed ID: 1247522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tissue factor pathway inhibitor in a revised coagulation cascade.
    Broze GJ
    Semin Hematol; 1992 Jul; 29(3):159-69. PubMed ID: 1641662
    [No Abstract]   [Full Text] [Related]  

  • 12. Inactivation of bovine and human thrombin and factor Xa by antithrombin III studied with amidolytic methods.
    Odegård OR; Abildgaard U; Lie M; Miller-Andersson M
    Thromb Res; 1977 Aug; 11(2):205-61. PubMed ID: 905972
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of daphnin on blood coagulation].
    Lakin KM; Kosheleva LI
    Farmakol Toksikol; 1968; 31(1):72-4. PubMed ID: 5675354
    [No Abstract]   [Full Text] [Related]  

  • 14. Protection of factor Xa from neutralization by the heparin-antithrombin complex.
    Teitel JM; Rosenberg RD
    J Clin Invest; 1983 May; 71(5):1383-91. PubMed ID: 6222069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of nitro-- derivatives of warfarin on blood coagulation].
    Lakin KM; Smirnova TV; Karaseva MG; Fel'dbaum VA
    Farmakol Toksikol; 1967; 30(4):456-60. PubMed ID: 5598901
    [No Abstract]   [Full Text] [Related]  

  • 16. [Protein synthesis induced by vitamin K deficiency].
    Hemker HC
    Nouv Rev Fr Hematol; 1970; 10(5):645-51. PubMed ID: 4250287
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence that antithrombin and the inhibitor of activated Stuart-Prower factor are separate entities.
    Osamo NO
    Blut; 1971 Nov; 23(5):280-6. PubMed ID: 5131050
    [No Abstract]   [Full Text] [Related]  

  • 18. Small doses of heparin and a new concept of hypercoagulability.
    Wessler S
    Thromb Diath Haemorrh; 1975 Feb; 33(1):81-6. PubMed ID: 1118831
    [No Abstract]   [Full Text] [Related]  

  • 19. Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.
    Chang YJ; Hamaguchi N; Chang SC; Ruf W; Shen MC; Lin SW
    Biochemistry; 1999 Aug; 38(34):10940-8. PubMed ID: 10460149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of the kinetics of inhibition of activated coagulation factor X in human plasma: the effect of plasma and inhibitor concentration.
    Jesty J
    Anal Biochem; 1986 Feb; 152(2):402-11. PubMed ID: 2421604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.